IGF2BP3 regulates macrophage-induced inflammation and liver damage in acute-on-chronic liver failure via the RORα-NF-κB signaling axis
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113030 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Ke Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplantation, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China; Engineering and Technology Resear…. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Macrophages, RNA-Binding Proteins, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Acute-on-chronic liver failure (ACLF) is a severe condition characterized by high mortality rates, and macrophage-mediated inflammation plays a critical role in its progression. Our previous research has indicated the involvement of the RNA-binding protein IGF2BP3 in the pathogenesis of ACLF. However, the underlying molecular mechanisms contributing to this damage require further elucidation. Initially, we observed heightened expression of pro-inflammatory cytokines and macrophage activation in both ACLF patients and a mouse model induced by D-GalN/LPS. Subsequent loss-of-function experiments targeting IGF2BP3 revealed that the knockdown of IGF2BP3 potentially confers hepatoprotection by mitigating macrophage-induced inflammation. Further investigation using RNA Immunoprecipitation (RIP) assays and dual luciferase reporter assays confirmed that RORα is a target protein of the RNA-binding protein IGF2BP3. Importantly, depletion of RORα was found to significantly increase liver damage and inflammation by modulating the NF-κB signaling pathway. In conclusion, our findings underscore the crucial role of IGF2BP3 in mediating liver damage induced by activated macrophages in ACLF, which is regulated by the RORα-NF-κB signaling pathway. These discoveries offer novel insights into the pathogenesis and potential therapeutic targets for ACLF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transplantation, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China; Engineering and Technology Research Center for Transplantation Medicine of National Health Commission,…
Zitieren
APA
Cheng, K., Liu, K., Liu, S., Zhao, Y., & Wang, Q. (2024). IGF2BP3 regulates macrophage-induced inflammation and liver damage in acute-on-chronic liver failure via the RORα-NF-κB signaling axis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113030
Vancouver
Cheng K, Liu K, Liu S, Zhao Y, Wang Q. IGF2BP3 regulates macrophage-induced inflammation and liver damage in acute-on-chronic liver failure via the RORα-NF-κB signaling axis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113030
BibTeX
@article{Cheng2024,
author = {Cheng, Ke and Liu, Kai and Liu, Shu and Zhao, Yujun and Wang, Qiang},
title = {IGF2BP3 regulates macrophage-induced inflammation and liver damage in acute-on-chronic liver failure via the RORα-NF-κB signaling axis},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113030}
}
EUVIMED